Welcome

Spectrum Therapeutics is an international medical cannabis company that raises the standard of care for patients with unmet medical needs. We make it easy for patients and healthcare professionals to understand how to optimize the therapeutic benefits of medical cannabis.

Learn more about how Spectrum Therapeutics can help you. Please verify your age to explore the complete website.

Please Enter A Valid Value Please Provide A Value
*

Required Field

I confirm that this is not a shared device.
or

Thank you for visiting Spectrum Therapeutics. You need to be of legal age to enter this site.

Loading...
Spectrum Therapeutics

Ogen Early Glue Rbx1 | Indica


THC 21–24 % THC | CBD < 1 % CBD | |

THC and CBD ranges may vary.

$60.00 /

Flower

Size Price Quantity
Login to select
Patient Login
Don’t have an account with us?

Flower flower

The Spectrum Therapeutics product packaging you receive with your order meets Health Canada's labelling regulations and will vary in appearance from what is displayed online. The images displayed here have been designed to improve your shopping experience by highlighting where your product fits in the Spectrum Framework.

OGEN Early Glue RBx1 is derived from the reverse back-cross of GG4 x Blackfire F-1 with the original GG4, creating a THC-dominant indica cultivar with minimal amounts of CBD. This strain’s small buds are coated in sticky trichomes delivering a more robust terpene profile that provides a distinctly creamy aroma with a funky floral finish.

THC and CBD ranges may vary. See product packaging for accurate levels.

L'emballage des produits Spectrum Therapeutics que vous recevez avec votre commande est conforme aux règlements de Santé Canada en matière d'étiquetage son aspect diffère de ce qui est affiché en ligne. Les images affichées sur cette page ont été élaborées afin d'améliorer votre expérience d'achat en soulignant où se situe le produit dans la gamme Spectrum.

OGEN Early Glue RBx1 est issu du rétrocroisement inverse de GG4 x Blackfire F-1 et de l’original GG4, créant ainsi un cultivar indiqua à dominance en THC contenant des quantités minimes de CBD. Les petits bourgeons de cette variété sont enrobés de trichomes adhésifs, ce qui lui confère un profil terpénique plus robuste, un arôme distinctement crémeux et des notes finales florales.

Les teneurs en THC et en CBD peuvent varier. Consultez l'emballage du produit pour connaître les teneurs exactes.

57%

5%

5%

7%

2%

19%

Caryophyllene
57
Limonene
5
Linalool
5
Myrcene
7
Pinene
2
Humulene
19


Quality Assurance Report

Quality Assurance Report